4 completed, 1 active not recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Active not recruiting 1 |
Follow Diethylcarbamazine: new trials by email Literature Review of Diethylcarbamazine trials Research Report on Diethylcarbamazine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis Ivermectin w/ Albendazole, Ivermectin + Diethylcarbamazine + Albendazole, Moxidectin + Albendazole - Onchocercal Subcutaneous Nodule, Onchocerciasis | Phase 2 | Active not recruiting | Washington University School of Medicine | 300 | 2024-04-05 | 2025-12-18 |
| PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) Azithromycin, Albendazole, Ivermectin - Lymphatic Filariasis, Yaws | Phase 2 | Completed | Lihir Medical Centre | 42 | 2018-09-01 | 2019-02-28 |
| Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa Diethylcarbamazine, Albendazole, Ivermectin - Lymphatic Filariasis | Phase 2 | Completed | University Hospitals Cleveland Medical Center | 182 | 2014-05-01 | 2018-10-09 |
| Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis Reslizumab, Diethylcarbamazine, Placebo - Loiasis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 31 | 2010-04-01 | 2022-01-27 |
| Effect of Albendazole Dose on Treatment of Lymphatic Filariasis Albendazole, Diethylcarbamazine - Lymphatic Filariasis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2007-07-01 | 2015-08-31 |
Elephantiasis, Filarial (3) · Filariasis (1) · Loiasis (1) · Onchocerciasis (1) · Onchocerciasis, Ocular (1) · Wounds and Injuries (1) · Yaws (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Lihir Medical Centre (1) · University Hospitals Cleveland Medical Center (1) · Washington University School of Medicine (1)
Papua New Guinea (2) · India (1) · Liberia (1) · United States (1)
Amy D Klion, M.D. (1) · Gary Weil, MD (1) · Patrick Kpanyen, PhD (1) · Peter Fischer, PhD (1) · Peter Siba, PhD (1) · Thomas B Nutman, M.D. (1)
PMID 26486704, PMID 30403937, PMID 32818264, PMID 37262040, PMID 42848323